fifteen drug-free patients with early to midstage huntington 's disease were evaluated with quantitative neurological examinations , scales for functional capacity , computed tomographic ( ct ) scans , and positron emission tomographic ( pet ) scans of 18f-2-fluoro-2-deoxyglucose ( 18f-fdg ) uptake .
C0220825
evaluated
C0027853
neurological examinations